Exagen Inc. buy BiotechBee
Start price
02.12.23
/
50%
€1.71
Target price
31.12.25
€2.60
Performance (%)
-
End price
04.12.23
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Exagen Inc. | - | - |
iShares Core DAX® | -0.383% | 5.021% |
iShares Nasdaq 100 | 1.248% | 4.007% |
iShares Nikkei 225® | 0.525% | -0.109% |
iShares S&P 500 | 0.640% | 3.649% |
According to BiotechBee what are the pros and cons of Exagen Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Exagen Inc. diskutieren
Buy mit Kursziel 2,6
In the thread Trading Exagen Inc.
Buy beendet